Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Name: Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial
SKU: 2744
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: aripiprazole, atypical-antipsychotics, bs, ccrc, gerardo-villarreal, gregory-toney, jacob-pickard, jose-m-cañive-md, lawrence-a-calais, ma, md, pharmd, ptsd, rn, s-laura-lundy

Description

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD

PB-40-2-02-Canive

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD

Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Ken Gersing, MD: Predicting Antipsychotic Use in Children

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

A Systematic Review of Augmentation Strategies for Major Depressive Disorder

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD

Related products

Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Ken Gersing, MD: Predicting Antipsychotic Use in Children

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

A Systematic Review of Augmentation Strategies for Major Depressive Disorder